These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 19957525)
1. [Relationship between serum prostate-specific antigen levels and body mass index in Beijing men over 50 years of age]. Wang Y; Zhou Z; Tian Y; Shao Q; Chen S; Hong BF; Zhang XH; Ren XH; Sun WX; Wang ZW; Na YQ Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(24):1681-3. PubMed ID: 19957525 [TBL] [Abstract][Full Text] [Related]
2. Body mass index influences prostate-specific antigen in men younger than 60 years of age. Kim YJ; Han BK; Hong SK; Byun SS; Kim WJ; Lee SE Int J Urol; 2007 Nov; 14(11):1009-12. PubMed ID: 17956528 [TBL] [Abstract][Full Text] [Related]
3. Effect of ageing and body mass index on prostate-specific antigen levels among Chinese men in Singapore from a community-based study. Chia SE; Lau WK; Chin CM; Tan J; Ho SH; Lee J; Cheng C BJU Int; 2009 Jun; 103(11):1487-91. PubMed ID: 19076145 [TBL] [Abstract][Full Text] [Related]
4. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men. Culp S; Porter M BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868 [TBL] [Abstract][Full Text] [Related]
5. Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening. Hutterer G; Perrotte P; Gallina A; Walz J; Jeldres C; Traumann M; Suardi N; Saad F; Bénard F; Valiquette L; McCormack M; Graefen M; Montorsi F; Karakiewicz PI Eur J Cancer; 2007 May; 43(7):1180-7. PubMed ID: 17292604 [TBL] [Abstract][Full Text] [Related]
6. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL; Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472 [TBL] [Abstract][Full Text] [Related]
7. Obesity and screening PSA levels among men undergoing an annual physical exam. Rundle A; Neugut AI Prostate; 2008 Mar; 68(4):373-80. PubMed ID: 18189231 [TBL] [Abstract][Full Text] [Related]
8. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic. Price MM; Hamilton RJ; Robertson CN; Butts MC; Freedland SJ Urology; 2008 May; 71(5):787-91. PubMed ID: 18267334 [TBL] [Abstract][Full Text] [Related]
9. Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program. Barqawi AB; Golden BK; O'Donnell C; Brawer MK; Crawford ED Urology; 2005 Apr; 65(4):708-12. PubMed ID: 15833513 [TBL] [Abstract][Full Text] [Related]
10. The prevalence of erectile dysfunction among Brazilian men screened for prostate cancer. Paranhos M; Antunes A; Andrade E; Freire G; Srougi M BJU Int; 2009 Oct; 104(8):1130-3. PubMed ID: 19426190 [TBL] [Abstract][Full Text] [Related]
11. Effect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen: results from a prostate cancer screening cohort of 1490 men. Capitanio U; Perrotte P; Hutterer GC; Suardi N; Jeldres C; Shariat SF; Duclos A; Arjane P; Montorsi F; Karakiewicz PI Int J Urol; 2009 Jan; 16(1):91-5. PubMed ID: 19054167 [TBL] [Abstract][Full Text] [Related]
12. Is the body mass index a predictor of adverse outcome in prostate cancer after radical prostatectomy in a mid-European study population? Pfitzenmaier J; Pritsch M; Haferkamp A; Jakobi H; Fritsch F; Gilfrich C; Djakovic N; Buse S; Pahernik S; Hohenfellner M BJU Int; 2009 Apr; 103(7):877-82. PubMed ID: 19007372 [TBL] [Abstract][Full Text] [Related]
13. [Clinical impact of body mass index on prostate biopsy in patients with intermediate PSA levels]. Sekita N; Suzuki H; Kamijima S; Chini K; Fujimura M; Mikami K Hinyokika Kiyo; 2008 Jul; 54(7):479-83. PubMed ID: 18697492 [TBL] [Abstract][Full Text] [Related]
14. Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition. Stroup SP; Cullen J; Auge BK; L'Esperance JO; Kang SK Cancer; 2007 Sep; 110(5):1003-9. PubMed ID: 17614338 [TBL] [Abstract][Full Text] [Related]
15. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer. Efstathiou JA; Skowronski RY; Coen JJ; Grocela JA; Hirsch AE; Zietman AL Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1302-8. PubMed ID: 18262732 [TBL] [Abstract][Full Text] [Related]
16. Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer. Ochiai A; Fritsche HA; Babaian RJ Urology; 2005 Oct; 66(4):819-23. PubMed ID: 16230145 [TBL] [Abstract][Full Text] [Related]
17. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study. Siddiqui SA; Inman BA; Sengupta S; Slezak JM; Bergstralh EJ; Leibovich BC; Zincke H; Blute ML Cancer; 2006 Aug; 107(3):521-9. PubMed ID: 16773619 [TBL] [Abstract][Full Text] [Related]
18. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175 [TBL] [Abstract][Full Text] [Related]
19. [The study on relationship of body mass index and blood pressure in children and adolescents of Beijing]. Wang WJ; Wang KA; Chen CM; Cao RX; Bai YM; Ma LM; Ren ZY; Niu ZH; Gao Q Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Feb; 25(2):109-12. PubMed ID: 15132860 [TBL] [Abstract][Full Text] [Related]